🔎 Trials Near Me

Akèy › Osteyosakòm

Etid klinik pou Osteyosakòm ap rekrite nan Etazini

52 etid pou Osteyosakòm ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

Ap rekriteFaz 1
Jiska laj 50 · Tout sèks · Mizajou Sep 30, 2026 · NCT06492954

The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

Ap rekriteFaz 2
Laj 7 a 22 · Tout sèks · Mizajou Sep 25, 2026 · NCT07560826

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Ap rekriteFaz 1/2
Jiska laj 26 · Tout sèks · Mizajou Sep 3, 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Ap rekriteFaz 1/2
Jiska laj 30 · Tout sèks · Mizajou Sep 3, 2026 · NCT06541262

Clinical Orthopaedic Data Bank (Acute and Chronic)

Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 3, 2026 · NCT00411060

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

Ap rekriteFaz 1/2
Laj 12 a 40 · Tout sèks · Mizajou Sep 3, 2026 · NCT07725380

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

Ap rekriteFaz 1
Laj 5 a 40 · Tout sèks · Mizajou Sep 3, 2026 · NCT06156410

Losartan + Sunitinib in Treatment of Osteosarcoma

Ap rekriteFaz 1
Laj 10 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT03900793

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Ap rekriteFaz 3
Jiska laj 50 · Tout sèks · Mizajou Aug 25, 2026 · NCT05235165

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

Ap rekrite
Tout laj · Tout sèks · Mizajou Aug 21, 2026 · NCT07514819

SPEARHEAD-3 Pediatric Study

Ap rekriteFaz 1/2
Laj 2 a 21 · Tout sèks · Mizajou Aug 11, 2026 · NCT05642455

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT05210374

Musculoskeletal Cancers Remote Monitoring and Care

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07129226

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07628634

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT04040205

AOH1996 for the Treatment of Refractory Solid Tumors

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT05227326

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Ap rekriteFaz 1
Laj 12 a 50 · Tout sèks · Mizajou Jul 15, 2026 · NCT03093909

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Ap rekriteFaz 2
Laj 0 a 50 · Tout sèks · Mizajou Jul 9, 2026 · NCT07321912

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Ap rekriteFaz 1/2
6 Months – 25 Years · Tout sèks · Mizajou Jun 30, 2026 · NCT06625190

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.